Clinical Trial Update: Healing of Intrabony Defects Following Treatment With PRF or EMD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing healing of intrabony periodontal defects treated with Platelet Rich Fibrin (PRF) versus Enamel Matrix Derivative (EMD) has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)
• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Semmelweis University | Conditions: Periodontal Bone Loss, Periodontal Disease | Phase 4 | Status: COMPLETED